JBS N.V. (JBS) AI Stock Analysis
JBS AI stock analysis summary
AI ResearchJBS N.V. (JBS) is a global animal protein processing company operating across beef, pork, poultry, and prepared foods. The company generated $91.17B in trailing twelve-month revenue, but quarterly earnings declined 57.2% in the latest quarter ending June 30, 2026. While its forward P/E of 3.9x trades at a discount to peers, total debt sits elevated at $24.44B.
- Market cap
- $13.95B
- Revenue (TTM)
- $91.17B
- P/E
- 12.2x fwd 3.9x
- 1Y return
- 10.6% S&P 500 16.8%
- Avg. target
- $18.57 42.5% vs last close
Bull case
- The stock trades at a forward P/E of 3.9x, well below the peer median of 14.3x for US-listed Consumer Defensive companies.
- Analysts hold a mean price target of $18.57, representing a 42.5% premium over the last close of $13.03.
- JBS provides an annual forward dividend of $1.00 per share, equating to a 7.67% dividend yield.
Bear case
- Total debt stands at $24.44B as of June 30, 2026, leading to a high debt-to-equity ratio of 2.97.
- Quarterly earnings fell 57.2% year-over-year in the latest quarter ending June 30, 2026.
- Analysts project EPS for the current fiscal year to decline 64.5% to $4.04.
What JBS does
JBS N.V., together with its subsidiaries, processes animal proteins worldwide, including beef, pork, lamb, and poultry. The company produces and markets prepared foods and operates related businesses in leather, collagen, hygiene and beauty products, metal packaging, and biodiesel. It offers products under brand names such as Seara, Doriana, Pilgrim's, Moy Park, Primo, Friboi, Maturatta, Swift, Ozo, and Adaptable Meals. Founded in 1953 and based in Amstelveen, the Netherlands, JBS employs 283,000 people and trades on the NYSE.
Growth and profitability
Annual revenue increased from $362.50B in FY2021 to $471.14B in FY2025, representing a 5-year revenue CAGR of 11.8% from FY2020 to FY2025. Net income rebounded from -$1.06B in FY2023 to $9.62B in FY2024 and reached $11.10B in FY2025, supporting FY2025 EPS of $8.80. Operating margin was 4.8% in FY2025, below the 9.2% recorded in FY2021. For the trailing twelve months, revenue stood at $91.17B with an operating margin of 3.1% and a profit margin of 1.2%. In the latest quarter ending June 30, 2026, quarterly revenue grew 13.8% year-over-year, while quarterly earnings fell 57.2%.
Balance sheet and cash flow
As of June 30, 2026, JBS held $3.47B in cash and short-term investments against total debt of $24.44B, resulting in net debt of $20.98B. The company maintains a current ratio of 1.53 and a debt-to-equity ratio of 2.97 on shareholders' equity of $8.22B. Operating cash flow reached $15.49B in FY2025, generating $4.13B in free cash flow after capital expenditures of $11.37B. Cash deployment in FY2025 included $8.81B in dividends paid and $3.19B in share buybacks.
Valuation and performance
At a last close of $13.03 on October 16, 2026, JBS carries a market capitalization of $13.95B and an enterprise value of $33.31B. The stock trades at a trailing P/E of 12.2x and a forward P/E of 3.9x, both below the median of its US-listed Consumer Defensive peers of 18.6x and 14.3x, respectively. Its EV to EBITDA multiple of 5.9x also sits below the peer median of 11.7x. Over the past year, JBS shares gained 10.6%, trailing the 16.8% return of the S&P 500 benchmark.
JBS dividend
JBS offers an annual forward dividend of $1.00 per share, representing a dividend yield of 7.67% based on its last close. The payout ratio stands at 16.5%. The stock's last ex-dividend date occurred on May 18, 2026, following $8.81B in total dividends paid during FY2025.
What analysts expect
Wall Street coverage consists of 8 Strong Buy, 5 Buy, and 2 Hold recommendations, with 0 Sell ratings. The mean price target of $18.57 implies an upside of 42.5% compared to the last close of $13.03. For the current fiscal year ending December 31, 2026, analysts estimate EPS of $4.04 and revenue of $475.76B. The company beat EPS estimates in 2 of the last 4 quarters, with the next earnings date scheduled for November 9, 2026.
Key risks and what to watch
- Net debt of $20.98B relative to cash and short-term investments of $3.47B exposes the company to debt service pressures.
- Trailing twelve-month profit margin is thin at 1.2%, leaving little room for error if operational costs escalate.
- Short interest represents 17.9% of the float, signaling significant market skepticism.
- The stock is down 2.4% year-to-date and trades 4.4% below its 200-day moving average.
AI-generated research summary. Written with AI from Quotelinks data as of October 16, 2026 and checked so every figure matches that data. For information only, not investment advice. Disclaimer
About this JBS AI stock analysis
This page is an AI-written research summary of JBS N.V. (JBS). The text was generated on October 30, 2026 from Quotelinks data as of October 16, 2026 (company profile, annual results, latest balance sheet, valuation, price performance and analyst estimates). An automatic check rejects any draft that contains a figure not found in that data. It is not investment advice; verify figures on the linked tabs before making decisions.
Related: JBS income statement, JBS balance sheet, JBS key metrics, JBS analyst forecast, JBS chart. See the JBS stock overview for the latest quote and news.
JBS AI stock analysis FAQ
What is JBS's dividend yield and payout?
JBS offers an annual forward dividend of $1.00, yielding 7.67% as of October 16, 2026. The company maintains a payout ratio of 16.5%, and its last ex-dividend date was May 18, 2026.
What are analysts' price targets for JBS?
The mean price target for JBS is $18.57, which is 42.5% above the last close of $13.03. The rating breakdown includes 8 Strong Buy, 5 Buy, and 2 Hold ratings.
How much debt does JBS carry?
As of June 30, 2026, JBS holds $24.44B in total debt and $3.47B in cash and short-term investments, resulting in net debt of $20.98B and a debt-to-equity ratio of 2.97.
When is the next earnings release for JBS?
The next earnings date for JBS is scheduled for November 9, 2026. For the current fiscal year ending December 31, 2026, analysts anticipate EPS of $4.04 on revenue of $475.76B.